Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketofol for reducing fentanyl-induced cough during general anesthesia
IRCT20150808023559N15Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Feb 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketofol, propofol, ketamine and fentanyl in cough (4 arms), sponsored by Ardabil University of Medical Sciences. Primary endpoints: Coughing and Cough beginning time. Started Feb 2018; status: completed.
02
Drugs
ketofolpropofolketaminefentanyl
03
Conditions
cough
Beyond the preview
Go deeper on IRCT20150808023559N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150808023559N15.